JSA Advises Biomapas Pinnaxis Acquisition: India PV Tech Boost

• Biomapas Group, a Carbyne Equity Partners portfolio company, acquired 100% of Pinnaxis IT Solutions and Consulting Private Limited.
• Pinnaxis specializes in pharmacovigilance technology and consulting services for the pharmaceutical and life sciences industries.
• JSA Advocates and Solicitors advised Biomapas Group on the acquisition, with Partner Sidharrth Shankar leading the transaction team.
• The deal involved a roll-over of investment into an overseas operating company and included specialized competition law advice.
• Pinnaxis's services include safety system implementation, data migration, validation, reporting, and managed services on leading safety platforms.

This transaction showcases JSA's expertise in cross-border M&A within the life sciences and pharmacovigilance technology sector in India, providing a relevant precedent for firms advising clients on similar strategic acquisitions or divestitures in this specialized industry.

The Biomapas Group, a company backed by Carbyne Equity Partners, has successfully completed the acquisition of Pinnaxis IT Solutions and Consulting Private Limited. This strategic move sees Biomapas taking full ownership of Pinnaxis, a firm specializing in pharmacovigilance technology and associated consulting services. The transaction encompassed the acquisition of 100% of the company's shares and notably included a roll-over of the investment into the overseas operating entity, underscoring a complex cross-border M&A deal.

This acquisition marks a significant development in the India pharmacovigilance tech acquisition landscape. Biomapas Group's integration of Pinnaxis IT Solutions is poised to enhance its capabilities within the critical domain of drug safety and monitoring. The deal highlights the growing interest and investment in specialized technology solutions supporting the pharmaceutical and life sciences sectors.

Pinnaxis IT Solutions and Consulting Private Limited has carved out a niche for itself through its comprehensive suite of services tailored for the pharmaceutical and life sciences industries. The company's expertise spans several crucial areas, including the implementation of robust safety systems, efficient data migration processes, and thorough validation services. Furthermore, Pinnaxis is recognized for its proficiency in reporting and providing managed services across various leading safety platforms.

These specialized offerings are vital for ensuring regulatory compliance and operational efficiency in pharmacovigilance, which involves the collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical products. The integration of Pinnaxis's deep technical and consulting knowledge into the Biomapas Group is expected to create a more formidable presence in this essential segment of healthcare technology.

JSA Advocates and Solicitors provided comprehensive legal counsel to the Biomapas Group throughout the acquisition process. The JSA Advocates and Solicitors M&A deal team was spearheaded by Partner Sidharrth Shankar, demonstrating the firm's leadership in complex corporate transactions. Key contributions to the transaction's successful execution also came from Partners Nandini Seth and Aditya Vardhan Dayal, alongside Senior Associates Pranav Rao N and Bulbul Tiwari. Associates Aditya Sinha, Aashreya Kodesia, and Rahul Nayyar, as well as Senior Company Secretary Vadi PS and Eshika Phadke, were integral members of the advisory team.

Addressing the regulatory aspects of the deal, the competition law facets were expertly managed by Partners Vaibhav Choukse and Ela Bali, supported by Associate Aarathi R Menon. This transaction showcases JSA's expertise in cross-border M&A within the life sciences and pharmacovigilance technology sector in India, providing a relevant precedent for firms advising clients on similar strategic acquisitions or divestitures in this specialized industry. The firm's multi-faceted legal support was crucial in navigating the intricacies of this significant Carbyne Equity Partners investment India.

This transaction showcases JSA's expertise in cross-border M&A within the life sciences and pharmacovigilance technology sector in India, providing a relevant precedent for firms advising clients on similar strategic acquisitions or divestitures in this specialized industry.

Source: Original reporting via legal industry publication